<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08594161371281</udiDi>
    <basicUdiDi>B-08594161371281</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Slovenia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:12.812Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371274</udiDi>
    <basicUdiDi>B-08594161371274</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Slovenia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:12.241Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371267</udiDi>
    <basicUdiDi>B-08594161371267</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:11.791Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371250</udiDi>
    <basicUdiDi>B-08594161371250</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:10.615Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371069</udiDi>
    <basicUdiDi>B-08594161371069</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:06.808Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371021</udiDi>
    <basicUdiDi>B-08594161371021</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Latvia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:05.696Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371014</udiDi>
    <basicUdiDi>B-08594161371014</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Latvia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:03.974Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371007</udiDi>
    <basicUdiDi>B-08594161371007</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:03.174Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370994</udiDi>
    <basicUdiDi>B-08594161370994</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:44.148Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370987</udiDi>
    <basicUdiDi>B-08594161370987</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:42.308Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370970</udiDi>
    <basicUdiDi>B-08594161370970</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:41.506Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370963</udiDi>
    <basicUdiDi>B-08594161370963</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:40.706Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370956</udiDi>
    <basicUdiDi>B-08594161370956</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:36.709Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370949</udiDi>
    <basicUdiDi>B-08594161370949</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:35.922Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370734</udiDi>
    <basicUdiDi>B-08594161370734</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Croatia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:35.119Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370727</udiDi>
    <basicUdiDi>B-08594161370727</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Croatia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:34.306Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370635</udiDi>
    <basicUdiDi>B-08594161370635</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Slovakia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:30.307Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370628</udiDi>
    <basicUdiDi>B-08594161370628</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Slovakia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:29.486Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370611</udiDi>
    <basicUdiDi>B-08594161370611</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:28.685Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370604</udiDi>
    <basicUdiDi>B-08594161370604</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Slovakia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:27.897Z</lastUpdated>
  </row>
</eudamedExport>